Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion type Assertion NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_head.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion description "[It has been speculated that production of cytotoxic products of SSAO may cause endothelial damage and thus contribute to the development of diabetic vascular complications such as retino-, nephro-, and neuropathies as a result of SSAO activity.In order to explore the possibility that high SSAO activity contributes to the development of vascular complications in diabetes, we have performed two studies in patients with Type-2 diabetes quantifying plasma SSAO activity, HbA(1c), and urinary levels of the SSAO substrate, methylamine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_provenance.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion evidence source_evidence_literature NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_provenance.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion SIO_000772 12686114 NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_provenance.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion wasDerivedFrom befree-20140225 NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_provenance.
- NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_assertion wasGeneratedBy ECO_0000203 NP477106.RAaBube8_ucHtTgbnOkKoyWo9NVBw10YGdsKvSE6RW18A130_provenance.